DNA templates with blocked long 3' end single-stranded overhangs (BL3SSO) promote bona fide Cas9-stimulated homology-directed repair of long transgenes into endogenous gene loci.


Journal

G3 (Bethesda, Md.)
ISSN: 2160-1836
Titre abrégé: G3 (Bethesda)
Pays: England
ID NLM: 101566598

Informations de publication

Date de publication:
07 08 2021
Historique:
received: 15 02 2021
accepted: 03 05 2021
pubmed: 15 5 2021
medline: 6 1 2022
entrez: 14 5 2021
Statut: ppublish

Résumé

Knock-in of large transgenes by Cas9-mediated homology-directed repair (HDR) is an extremely inefficient process. Although the use of single-stranded oligonucleotides (ssODN) as an HDR donor has improved the integration of smaller transgenes, they do not support efficient insertion of large DNA sequences. In an effort to gain insights into the mechanism(s) governing the HDR-mediated integration of larger transgenes and to improve the technology, we conducted knock-in experiments targeting the human EMX1 locus and applied rigorous genomic PCR analyses in the human HEK293 cell line. This exercise revealed an unexpected molecular complication arising from the transgene HDR being initiated at the single homology arm and the subsequent genomic integration of plasmid backbone sequences. To pivot around this problem, we devised a novel PCR-constructed template containing blocked long 3' single-stranded overhangs (BL3SSO) that greatly improved the efficiency of bona fide Cas9-stimulated HDR at the EMX1 locus. We further refined BL3SSO technology and successfully used it to insert GFP transgenes into two important interferon-stimulated genes (ISGs) loci, Viperin/RSAD2, and ISG15. This study demonstrates the utility of the BL3SSO platform for inserting long DNA sequences into both constitutive and inducible endogenous loci to generate novel human cell lines for the study of important biological processes.

Identifiants

pubmed: 33989385
pii: 6275753
doi: 10.1093/g3journal/jkab169
pmc: PMC8496256
pii:
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : R01 AG052465
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM135215
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD088792
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Genetics Society of America.

Auteurs

Saptaparni Bandyopadhyay (S)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

Joseph Douglass (J)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

Sebastian Kapell (S)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.

Nazimuddin Khan (N)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.

Fabiana Feitosa-Suntheimer (F)

National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.

Jenny A Klein (JA)

Department of Biology, Brandeis University, Waltham, MA 02453, USA.
Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

Jasmine Temple (J)

Department of Biology, Brandeis University, Waltham, MA 02453, USA.

Jayce Brown-Culbertson (J)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

Alexander H Tavares (AH)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.

Mohsan Saeed (M)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.

Nelson C Lau (NC)

Department of Biochemistry, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Genome Science Institute, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH